Glomerular macrophage phagocytic activity in experimental immune complex glomerulonephritis. In rats with the proliferative immune complex glomerulonephritis of chronic serum sickness, kidney function deteriorates in three clearly distinguishable and discrete stages: mild, moderate and severe. The macrophage component of glomerular inflammation in each stage is also quantitatively and qualitatively distinct, with abnormal phenotypic markers appearing in the moderate stage and increasing in the severe stage. To determine whether there were distinct functional differences among macrophages from the three stages, Fcy receptor-mediated phagocytic capacity was measured. The phagocytic capacity of glomerular macrophages increased significantly in the moderate stage, then significantly decreased, as rats progressed to severe chronic serum sickness. This decline in phagocytic function was not associated with a decrease in the expression of Fcy receptors on the glomerular macrophage cell surface. Furthermore, the phagocytic function of peritoneal macrophages from rats with severe chronic serum sickness was not impaired. Whether or not this attenuation of glomerular macrophage phagocytic capacity is the cause, or result, of renal disease progression remains unclear. It may indicate a potentially protective role for intraglomerular macrophages, and can serve as an additional functional marker of disease progression.
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Chronic serum sickness in rats is a model of human proliferative glomerulonephritis that allows for the study of the relationship between kidney pathophysiology and immunopathology [1] . Three discrete stages of nephritis have been defined. Those stages, designated mild, moderate and severe, are each clearly distinguishable by characteristic immunopathologic and pathophysiologic features [2] [3] [4] [5] [6] . A significant glomerular hypercellularity develops in the moderate stage that is largely attributable to the accumulation of macrophages, some of which express abnormal phenotypic markers [6] . During the severe stage of nephritis, which is characterized by an irreversible decline in glomerular filtration rate [2] , the number of glomerular macrophages and the percentage expressing abnormal phenotypic markers, increases even further [2, 4, 6] . There is substantial evidence that macrophages contribute significantly to the pathogenesis of both acute and chronic proliferative immune complex glomerulonephritis [7] [8] [9] [10] [11] [12] [13] [20] , has been postulated to contribute to the progression of the lesions of immune complex glomerulonephritis. We wished to determine if the changes in macrophage phenotype that accompany the progression of immune complex nephritis were correlated with functional changes in those cells. For that reason, Fcy receptor-mediated phagocytosis was measured in vitro at each of the three stages of chronic serum sickness; the function of glomerular macrophages was compared to that of the resident peritoneal macrophages from normal rats as well as that of peritoneal macrophages from rats in each of the stages of chronic serum sickness. A specific association between glomerular macrophage phagocytic function and disease progression has not previously been demonstrated.
Methods

Induction and monitoring of chronic serum sickness
Female LEW rats (Charles River Breeding Laboratories), weighing 125 to 150 g received four subcutaneous injections of 3 mg of bovine serum albumin (BSA) in incomplete Freund's adjuvant at two week intervals as previously described [1, 21] , until precipitating antibodies to BSA with titers (log2) 16 were produced. Gradually increasing amounts of daily intravenous BSA injections were given until the rats tolerated a single daily intravenous injection of 2 mg BSA in 0.4 ml isotonic saline [1, 21] . Urine samples were collected at least twice per week from animals kept overnight (16 hr) in metabolism cages. At the end of each urine collection period, 100 .d of blood were obtained from the tail vein. Protein, albumin, creatinine and sodium concentrations in urine and plasma were measured as previously described [2, 4] .
The criteria for distinguishing the stages of chronic serum sickness were as previously described (Table 1 ) [2] [3] [4] [5] [6] . Briefly, normal protein excretion ( 25 mg124 hr), normal creatinine clearance ( 0.50 ml/min x 100 g body wt) and normal sodium excretion ( 0.25 mEqI24 hr x 100 g body wt) were characteristic of the mild stage. The moderate stage begins with the sudden onset of proteinuria, while normal creatinine clearance was maintained. The severe stage begins with an abrupt decrease in both creatinine clearance (0.25 mllmin) and sodium excretion ( 0.20 mEq/24 hr), accompanied by further increases in urinary protein excretion. In addition to these pathophysiologic parameters, there are also quantitative and phenotypic changes in the glomerular macrophage population that distinguish each stage of nephritis (Table 1) [61.
Buffers and media Isotonic veronal buffered saline (VBS), 0.01 M EDTA buffer and dextrose veronal buffered saline (DVBS) were prepared as previously described [22, 23] . Hanks balanced salt solution with and without calcium and magnesium (HBSS and HBSS, respectively) and RPMI 1640 were obtained from GIBCO (Grand Island, New York, USA). Hypotonic saline buffer containing 0.66 M ammonium chloride, 3.7 x i0 M potassium carbonate and 1.1 >( lO M EDTA (lysing buffer) was prepared in our laboratory.
Preparation of opsonized sheep erythrocytes
Sheep erythrocytes (E) were washed with 0.01 M EDTA buffer and VBS buffer before suspension in VBS at 1 x io cells/mi. A portion of E was suspended in DVBS and a 1:100 dilution of rabbit anti-sheep IgG (Diamedix, Miami, Florida, USA) or rat anti-sheep IgG (provided by Dr. William Chambers, Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA) was added followed by a 15 minute incubation at 37°C to form opsonized sheep erythrocytes (EIgG). These cells were then washed three times in DVBS. Both E and EIgG were resuspended in DVBS at 1.5 x 108 cells/ml for use in phagocytosis and rosetting assays.
Isolation of glomerular macrophages
Glomerular macrophages were isolated from the kidneys of normal, age-matched control rats and from each stage of chronic serum sickness glomerulonephritis, as previously described [24] . Briefly, rat kidneys were perfused in situ with sterile PBS, then removed. Glomerular isolation was accomplished by compressing slices of cortex through 60-, 100-and 200-mesh steel sieves. Cell dissociation was accomplished by a three-stage procedure. First the glomeruli were incubated for 20 minutes at 37°C with shaking, in a cocktail consisting of 5 mg trypsin type II, 10 mg collagenase type I and 1 mg deoxyribonuclease type IV (all from Sigma) in 10 ml HBSS. Secondly, the cells were incubated in 2 mM EDTA in HBSS for 30 minutes at 37°C. The supernatant was removed and placed on ice, and the precipitate was incubated for 20 minutes at 37°C in 10 ml HBSS containing 10 mg collagenase. The suspension was washed with HBSS then passaged through a 23 gauge needle three times. The cells were allowed to settle on ice for five minutes, then the supernatants were washed twice with 5% heat-inactivated FCS (GIBCO) in HBSS. These cells were then suspended at 1.5 x 106 cells/mI in HBSS with 10% heatinactivated FCS then plated in slide-mounted, eight-chamber tissue culture plates (Nunc, Inc., Naperville, Illinois, USA).
After an overnight incubation at 37°C in 5% CO2 chamber, the slides were washed vigorously three times with RPM! to remove any non-adherent cells. Staining with the monoclonal antibody ED! (Bioproducts for Science) confirmed that > 95% of the adherent cells were macrophages [25] . There were no significant differences in the number of glomeruli isolated from each stage of disease (approximately 4 x l0 per rat in each case, with kidneys from rats with severe disease yielding an average of 5 x 1O glomeruli per rat). However, as expected from histologic studies [6] , larger numbers of macrophages were isolated from the moderate and severe stages of disease.
Means SEM were as follows: 9 x 106 0.5 x 106 macrophages per rat with severe chronic serum sickness; 5 x 106 0.4 x 106 per rat with moderate chronic serum sickness; 1.5 x 106 0.4 x 106 per rat with mild disease; 1 X 106 0.3 x 106 per normal, age-matched rat. The pattern of isolated glomerular macrophage staining with the monoclonal antibodies ED2 and ED3 were the same as previously reported in situ (Table 1) 
Specifically, approximately 40% of glomerular macrophages from the moderate stage and 80% of glomerular macrophages from the severe stage stained positively with ED3. Approximately 10% of glomerular macrophages from the severe stage also stained positively with ED2.
Isolation of peritoneal macrophages
Resident peritoneal macrophages were obtained from normal rats and rats at each stage of chronic serum sickness by repeated gentle lavages of the peritoneal surface with RPM! 1640, after exsanguination of the animals by cardiac puncture under anesthesia. The peritoneal cells were washed three times in RPM! 1640 and suspended at 5 x l0 cells/ml. 250 pi of the cell suspension were added to each chamber of slide-mounted, eight-chamber tissue culture plates (Nunc) for phagocytosis and rosetting experiments. Staining with the monoclonal antibody ED! confirmed > 95% of these cells to be macrophages.
Peritoneal macrophages from normal rats stained positively with ED! and ED2, but not ED3. However, >90% peritoneal macrophages from rats at each stage of chronic serum sickness stained positively for ED2 and ED3. Activated peritoneal macrophages were obtained from normal rats following intraperitoneal injection of 2.5 ml complete Freund's adjuvant (CFA). Two weeks after the adjuvant injections, cells were harvested as described above for resident macrophages, for use in phagocytosis and rosetting assays. More than 90% of those peritoneal macrophages stained positively with ED1, ED2 and ED3.
Phagocytosis assays
Two hundred and fifty microliters of RPMI 1640 were added to each chamber of the slide-mounted tissue culture plates on which the macrophages were adhered. The cells were then placed in a 37°C, 5% CO2 incubator for 30 minutes to allow for equilibration. To assess Fcy receptor (FcyR)-mediated phagocytosis, 100 d of either E (to, determine nonspecific ingestion) or EIgG were then added to each chamber and the plates were centrifuged at 50 x g for five minutes at 4°C. After centrifugation, the cells were again placed in a 37°C incubator with 5% CO2 and phagocytosis was allowed to proceed for one hour. Phagocytosis was stopped by rinsing with 0°C lysing buffer to remove non-internalized E. After two exposures to lysing buffer, the cells were fixed with 1% glutaraldehyde and stained with Giemsa. The percentage of macrophages in each chamber that had ingested one or more E was determined by light microscopy (l000x; oil immersion). The total number of E ingested by these macrophages was also counted. The results of the latter were expressed as the phagocytic index (P1), the total number of ingested E per 100 macrophages.
Peritoneal macrophages, exposed to the three-step enzymatic process used to isolate glomerular macrophages for phagocytosis assays, did not differ from untreated cells in phagocytic capacity or phenotypic marker expression. Therefore, subsequent experiments with peritoneal macrophages did not incorporate those procedures.
Rosetting assays
Macrophages were plated in slide-mounted, eight-chamber tissue culture plates (Nunc), as described for the phagocytosis assays (see above). After the addition of E (to determine nonspecific binding) or EIgG, however, the cells were incubated at 37°C with 5% CO2 for only 30 minutes to allow for attachment but preclude ingestion. The slides were then rinsed gently with RPMI x 3 to remove non-adherent E. The slides were fixed with 1% glutaraldehyde, stained with Giemsa and examined with a light microscope at 400 x. Macrophages with 3 erythrocytes attached were counted as positive, as previously described [26] . Exposure of peritoneal cells to the threestep enzymatic process used to isolate glomerular macrophages did not alter their rosetting capacity in pilot control studies. Subsequent experiments did not include those enzymatic steps.
Statistical analysis
In all experiments each sample was run in triplicate. Six to eight rats were used from each stage of chronic serum sickness for glomerular macrophage experiments; three rats from each stage for peritoneal macrophage experiments. Data are expressed as the mean SEM. Analysis of variance was used for comparison of different progressive stages of chronic serum sickness, followed by Scheffe (post-hoc) adjustments for the data. P values 0.05 were considered significant.
Results
Phagocytic capacity
As expected, peritoneal macrophages from normal rats activated by complete Freund's adjuvant had a significantly increased phagocytic capacity as compared to nonactivated normal peritoneal macrophages (53.6% vs. 25.3%; P = 0.02), validating the experimental protocol. The phagocytic capacity of glomerular macrophages from rats with mild chronic serum sickness glomerulonephritis was indistinguishable from that of normal pentoneal macrophages or normal glomerular macrophages ( Fig. 1) . It was, however, significantly less than that of peritoneal macrophages from the same disease stage (31.9 1.8% vs. 61.7 2.0%, respectively; P < 0.01). Glomerular macrophages from rats with moderate chronic serum sickness glomerulonephritis had a significantly increased phagocytic capacity compared with those from rats with mild disease (49. 1 7.8% vs. 31.9 1.8%, respectively; P < 0.05). There was no statistically significant difference in the phagocytic capacity of peritoneal and glomerular macrophages from rats with moderate disease. Glomerular macrophages isolated from rats which had progressed to severe chronic serum sickness showed a significant reduction (P < 0.0001) in phagocytic capacity compared with cells from rats with moderate disease (22.2 2.9% vs. 49.1 7.8%, respectively; Fig. 1 ). There was no difference between the phagocytic capacity of glomerular macrophages isolated from rats with severe chronic serum sickness glomerulonephritis and resident peritoneal macrophages isolated from normal rats. However, there was a significant decrease in phagocytosis compared with peritoneal macrophages from animals with severe disease. The phagocytic capacity of peritoneal macrophages from rats at each stage of chronic serum sickness was elevated compared with normal peritoneal macrophages and equivalent to that of CFA-activated peritoneal macrophages from normal rats (Fig. 1) . Ingestion of nonopsonized E was < 3% in all experiments.
The phagocytic index was also increased for glomerular macrophages from rats with moderate chronic serum sickness and peritoneal macrophages from all three stages of disease (Fig. 2 ). In addition, during moderate chronic serum sickness nephritis, individual glomerular macrophages ingested a greater number of opsonized erythrocytes than during the other stages of disease (Table 2) .
Macrophage Fc7R expression
EIgG rosette formation was measured as an index of macrophage FcyR expression. Normal resident peritoneal macrophages made significantly fewer rosettes than peritoneal and glomerular macrophages obtained from animals at each stage of chronic serum sickness (Fig. 3 ). There was no significant difference between the number of rosettes formed with normal glomerular and normal peritoneal macrophages. There was no significant difference between the percent of glomerular or peritoneal macrophages forming rosettes at each stage of chronic serum sickness glomerulonephritis. Rosette formation with nonopsonized E was <2% for all experiments. present in the kidney [16, 17] . This function has generally been thought to contribute to renal damage through the production and/or release of proteinases, oxidants, prostaglandins, leukotrienes, cytokines, complement components and coagulation factors [181. There has been much support for this position, as it has been shown that depletion of macrophages prior to induction of glomerulonephritis abrogates cellular infiltration and the associated proteinuria [12, 13, 27] . Additionally, there is documentation that intraglomerular macrophages are activated in immune complex glomerulonephritis [6, 28] . It was therefore not surprising to find increased phagocytic capacity of intraglomerular macrophages to levels equal to that of peritoneal a) 0 macrophages exposed to complete Freund's adjuvant. What was unexpected, however, was the decreased glomerular macrophage phagocytic capacity found as chronic serum sickness progressed from the moderate to severe stage, in light of phenotypic markers suggesting a possible increase in activation state. It is unclear whether the decrease in phagocytic capacity is the cause, or effect, of disease progression; an inability to clear immune complexes deposited in the kidney has been postulated to contribute to the progression of immune complex nephritis [19, 20] . At the very least, the decrease in phagocytosis may be considered an immunopathologic marker of gbmerular macrophage dysfunction. This new data correlate a functional anomaly with the phenotypic abnormalities previously reported ( Our data also show that this attenuation of glomerular macrophage phagocytic capacity in the severe stage of chronic serum sickness results from decreased FcyR function, not decreased FcR expression. Gbomerular macrophage FcyR expression was elevated at each stage of nephritis compared with both normal and activated peritoneal macrophages, yet only 30% of the glomerular macrophages which expressed Fc7R demonstrated phagocytic activity in severe nephritis. This compares with 53% for normal peritoneal macrophages, 55% for normal glomerular macrophages, 67% for moderate glomerular macrophages and 68% for severe peritoneal macrophages. The combination of a larger percentage of phagocytic glomerular macrophages and the greater number of erythrocytes ingested by individual macrophages during moderate chronic serum sickness nephritis may be a subtle indicator of "superactivation." On the other hand, the low level of glomerular macrophage phagocytic capacity during severe nephritis, despite increased Fc7R expression, may either reflect the action of a direct or indirect inhibitor of FcyR function, or a generalized exhaustion of cell energy sources due to continual immune complex ingestion.
The production and possible role of the cytokines IL-i and TNF in some animal models of glomerulonephritis, including chronic serum sickness, has been previously reported [6, [29] [30] [31] [32] [33] . Both of these soluble mediators may act to increase macrophage phagocytic capacity [34] . However, other immunologically active substances may also be secreted during the severe stage of disease by the highly abnormal ED3 + glomerular macrophages, or other glomerular cells, which counteract the known stimulatory effects of IL-i and TNF. One potential candidate for abrogation of an IL-i effect is IL-i receptor antagonist (IL-iRa). Adherent IgG can induce production of this cytokine by human mononuclear cells [35] . IL-IRa specifically binds to the IL-l receptor, inhibiting the actions of IL-i and could possibly result in a decrease of the high macrophage phagocytic activity noted in the moderate stage of disease.
Studies are currently underway to test this hypothesis. Another potential inhibitory candidate is IL-2, secreted by T cells, which are known to be present during the moderate stage of disease (Table 1 ) [6] . IL-2 has been shown to inhibit TNF stimulation of phagocytosis in polymorphonuclear leukocytes [36] , and a similar phenomenon may be occurring with the glomerular macrophages in this study.
Fc receptor function of peripheral human mononuclear cells in patients with glomerulonephritis secondary to various autoimmune diseases has been shown to be significantly reduced both in vivo and in vitro [37] [38] [39] . Continual ingestion of immune complexes with consequent exhaustion of cell energy source has been postulated as the explanation for the impaired phagocytic capacity. Most of the glomerular macrophages in the severe stage of chronic serum sickness have abnormal phenotypes [6] , which is suggestive of an activated metabolic state. This lends support to the hypothesis of cell exhaustion. Additionally, circulating immune complexes are highest in the mild stage and lowest in the severe stage [40] . However, it is unclear whether gbomerular macrophage phagocytic capacity is reflective of peripheral mononuclear cell function as chronic serum sickness progresses, since a large number of the gbomerular macrophages arise by local proliferation [41] . In addition, the phagocytic capacity of peritoneal macrophages from animals with severe disease is not impaired, as compared with other disease stages or normal animals. It would therefore appear that there is local, rather than general inhibition of macrophage phagocytic function. This type of differential response at sites of local inflammation has been described in other situations.
Differences in local expression of complement genes in a munne model of lupus nephritis has been reported [42] , and recently, differences in the response of synovial fluid macrophages and peripheral blood monocytes to IL-4 have been reported [43] . A recent report from our laboratory indicates that the expression of phenotypic markers of macrophage activation can be prevented in chronic serum sickness by treatment with cyclosporin A [44] . 
